Two patients present with pink plaques on different parts of their head and face. Can you correctly identify each case?

Ruxolitinib 0.75% cream and ruxolitinib 1.5% cream are effective and well-tolerated in children aged 2 to 11 years with atopic dermatitis.

Immunosuppression was identified as a significant independent predictor of poor outcomes among patients with cutaneous squamous cell carcinoma.

Subcutaneous infliximab therapy alone is associated with higher immunogenicity than IV infliximab and an immunomodulator combined.

The FDA has accepted for review the NDA for linerixibat for the treatment of cholestatic pruritus in patients with primary biliary cholangitis.

Patients with metastatic melanoma in mitochondrial haplogroup T are significantly less likely to respond to immunotherapy.

The standard regimen of omalizumab is often modified in patients with chronic spontaneous urticaria, with several factors predicting dose adjustments.

Multimorbidity is common in SSc and is linked to reduced survival and physical function, particularly among patients with cardiovascular and renal comorbidities.

Treatments for multiple myeloma, melanoma, NSCLC, phenylketonuria, C3 glomerulopathy and primary immune complex membranoproliferative glomerulonephritis are under review.

Patients with psoriasis who have high levels of serum 25-hydroxyvitamin D have a decreased risk for incident cardiovascular disease and mortality.

Dog exposure was linked to significant changes in some genetic factors associated with risk for atopic eczema.

TikTok videos for children's skincare frequently feature potentially irritating products and often exclude sunscreen.